Stock TMCI TREACE MEDICAL CONCEPTS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Market Closed - Nasdaq
Other stock markets
 21:00:00 01/05/2024 BST 		5-day change 1st Jan Change
10.86 USD +4.73% Intraday chart for Treace Medical Concepts, Inc. +1.78% -14.82%
03-25 Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction MT
02-27 Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction
Treace Medical Concepts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Year 2024
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Treace Medical Concepts Says Post-Market Study of Lapiplasty Shows Patients Report 'Positive' Outcomes
Treace Medical Concepts, Inc. Announces Three-Year Interim Data from Its Align3d?? Post-Market Study Supporting the Use of the Lapiplasty Procedure for Treating Bunions
Treace Medical Concepts Expects Q4 Revenue of Up to $62 Million
Sector Update: Health Care Stocks Advance Premarket Friday
Treace Medical Concepts Q3 Adjusted Loss Widens, Revenue Rises; Lowers Annual Revenue Outlook
Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Treace Medical Concepts, Inc. Revises Revenue Guidance for the Year 2023
Treace Medical Concepts, Inc. Highlights New Product Innovations and Updated Align3d Clinical Study Data At the American Orthopaedic Foot & Ankle Society Annual Meeting 2023
Treace Medical Concepts, Inc. Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures
Treace Medical Concepts, Inc. Appoints Nathan Minnich as Senior Vice President, Marketing
Treace Medical Concepts Q2 Adjusted Loss Narrows, Revenue Rises; 2023 Revenue Outlook Lifted
Treace Medical Concepts, Inc. Revises Revenue Guidance for the Year 2023
Treace Medical Concepts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Treace Medical Concepts, Inc. Appoints Julie Dewey as Chief Communications and Investor Relations Officer, Effective July 17, 2023
Treace Medical Concepts, Inc. completed the acquisition of certain assets of MIOS Marketing, LLC.
Insider Sell: Treace Medical Concepts
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TMCI Stock
  4. News Treace Medical Concepts, Inc.
  5. Other languages